Proactive Investors - Run By Investors For Investors

HEXO stock soars after Newstrike acquisition

The all-stock agreement is valued at C$263 million
The final puzzle piece about to be placed in a space that says 'acquistion'
HEXO is hoping for $400 million in net revenue in fiscal 2020 from the Newstrike deal

HEXO Corp (NYSEAMERICAN:HEXO) entered into an agreement to buy Newstrike Brands Ltd (TSX:HIP) (OTC:NWKRF) in an all-stock deal worth C$263 million. the company announced Wednesday.

The deal gives the medical and adult-use cannabis producer an additional capacity of about 150,000 kg of cannabis annually and expand its distribution reach to eight Canadian provinces. The Gatineau, Quebec-based company will also gain access to four production campuses featuring nearly 1.8 million square feet of cultivation space.

Shares jumped 6.7% to $5.95 in New York.

READ: Buds & Duds: HEXO, Weekend Unlimited lead a surging cannabis sector

HEXO expects the deal to boast annual benefits of $10 million and hopes to achieve more than $400 million in net revenue in fiscal 2020.

“With Newstrike, we're adding talented employees and infrastructure to take HEXO to the next level on our journey to become one of the largest cannabis companies in the world.” CEO and co-founder Sebastien St-Louis said. “We're extremely proud of our record of execution.”

As part of the deal, Newstrike shareholders will receive less than 0.1 HEXO common shares for every Newstrike common share they own.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full HEXO profile View Profile

Hexo Corporation Timeline

Related Articles

cannabis on dollar bills
June 08 2019
Australis invests in the highly fragmented, rapidly evolving US cannabis space, with a focus on building companies through early-stage, diversified and opportunistic investments
Strainsecure platform
June 19 2019
The company’s blockchain-based platform is designed to guarantee product quality and genetics throughout the cannabis supply chain from genome to patient
Cannabis leaf
November 19 2018
With the legalisation of recreational cannabis in Canada in October, and the US expected to follow suit, the company has its sights set on building up the very best in the industry
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use